197 related articles for article (PubMed ID: 12798651)
1. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection.
Fralish BH; Tarleton RL
Vaccine; 2003 Jun; 21(21-22):3070-80. PubMed ID: 12798651
[TBL] [Abstract][Full Text] [Related]
2. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
Garg N; Tarleton RL
Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
[TBL] [Abstract][Full Text] [Related]
4. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
5. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
[TBL] [Abstract][Full Text] [Related]
10. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
[TBL] [Abstract][Full Text] [Related]
11. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.
Giddings OK; Eickhoff CS; Sullivan NL; Hoft DF
Infect Immun; 2010 Mar; 78(3):1333-8. PubMed ID: 20048046
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
Pereira-Chioccola VL; Costa F; Ribeirão M; Soares IS; Arena F; Schenkman S; Rodrigues MM
Parasite Immunol; 1999 Feb; 21(2):103-10. PubMed ID: 10101720
[TBL] [Abstract][Full Text] [Related]
13. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection.
Morell M; Thomas MC; Caballero T; Alonso C; López MC
Vaccine; 2006 Nov; 24(49-50):7046-55. PubMed ID: 16901590
[TBL] [Abstract][Full Text] [Related]
14. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
[TBL] [Abstract][Full Text] [Related]
15. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.
Planelles L; Thomas MC; Alonso C; López MC
Infect Immun; 2001 Oct; 69(10):6558-63. PubMed ID: 11553607
[TBL] [Abstract][Full Text] [Related]
16. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
[TBL] [Abstract][Full Text] [Related]
17. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
[TBL] [Abstract][Full Text] [Related]
19. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
20. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]